Gamida Cell to Present at the 31st Annual Piper Jaffray Healthcare Conference
BOSTON--(BUSINESS WIRE)--Nov 21, 2019--
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced that Julian Adams, Ph.D., the company’s chief executive officer, will participate in a “fireside chat” at the 31 st Annual Piper Jaffray Healthcare Conference on Thursday, December 5, 2019, at 1:00 p.m. ET in New York City.
A live webcast of the presentation will be available on the Investors section of the Gamida Cell website, www.gamida-cell.com, and will be available for 30 days following the event.
About Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. For additional information, please visit www.gamida-cell.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191121005114/en/
CONTACT: Jaren Irene Madden
KEYWORD: NEW YORK MASSACHUSETTS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ONCOLOGY
SOURCE: Gamida Cell Ltd.
Copyright Business Wire 2019.
PUB: 11/21/2019 08:01 AM/DISC: 11/21/2019 08:01 AM